WallStreetZenWallStreetZen

NASDAQ: INVO
Invo Bioscience Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

INVO past revenue growth

How has INVO's revenue growth performed historically?
Company
267.38%
Industry
9.47%
Market
17.2%
INVO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INVO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INVO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INVO earnings and revenue history

Current Revenue
$3.0M
Current Earnings
-$8.0M
Current Profit Margin
-266%

INVO Return on Equity

Current Company
N/A
Current Industry
10.5%
Current Market
188%

Be the first to know when INVO announces earnings.

INVO Return on Assets

Current Company
-60.5%
Current Industry
5.3%
INVO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INVO Return on Capital Employed

Current Company
-55.89%
Current Industry
8.3%
INVO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INVO vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INVO$3.02M-$6.88M-$8.03M+43.62%N/A
TNON$2.93M-$15.13M-$15.58M+403.75%N/A
DYNT$35.18M-$3.40M-$5.70M-11.84%N/A
XYLO$91.72M-$16.10M-$16.03M+191.47%N/A
NAOV$2.28M-$3.44M-$3.71M+48.33%N/A
View Top Medical Device Stocks

INVO earnings dates

Next earnings date
May 13, 2024

Invo Bioscience Earnings & Revenue FAQ

What were INVO's earnings last quarter?

On Invalid Date, Invo Bioscience (NASDAQ: INVO) reported Q4 2023 earnings per share (EPS) of $0.63, up 113.85% year over year. Total Invo Bioscience earnings for the quarter were -$1.99 million. In the same quarter last year, Invo Bioscience's earnings per share (EPS) was -$4.55.

If you're new to stock investing, here's how to buy Invo Bioscience stock.

What was INVO's earnings growth in the past year?

As of Q2 2024, Invo Bioscience's earnings has grown year over year. Invo Bioscience's earnings in the past year totalled -$8.03 million.

What is INVO's earnings date?

Invo Bioscience's earnings date is Invalid Date. Add INVO to your watchlist to be reminded of INVO's next earnings announcement.

What was INVO's revenue last quarter?

On Invalid Date, Invo Bioscience (NASDAQ: INVO) reported Q4 2023 revenue of $1.38 million up 396.78% year over year. In the same quarter last year, Invo Bioscience's revenue was $278.14 thousand.

What was INVO's revenue growth in the past year?

As of Q2 2024, Invo Bioscience's revenue has grown 267.38% year over year. This is 257.91 percentage points higher than the US Medical Devices industry revenue growth rate of 9.47%. Invo Bioscience's revenue in the past year totalled $3.02 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.